Cognition Therapeutics (CGTX) Gains from Investment Securities (2024)
Cognition Therapeutics (CGTX) posted quarterly Gains from Investment Securities of $195000.0 for Q1 2024.
Cognition Therapeutics (CGTX) Gains from Investment Securities (2024) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Gains from Investment Securities for 1 consecutive years, with $195000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Gains from Investment Securities changed N/A year-over-year to $195000.0; the TTM figure through Dec 2024 stood at $195000.0 (changed N/A YoY), while the FY2024 annual figure was $195000.0, changed N/A from the prior year.
- Gains from Investment Securities held at $195000.0 in Q1 2024 per CGTX's latest filing.
- Across five years, Gains from Investment Securities topped out at $195000.0 in Q1 2024 and bottomed at $195000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 195,000.00 |
| Mar 31, 2024 | 195,000.00 |